BMEZ · Insider Trading
BlackRock Health Sciences Term Trust
Every open-market purchase and sale reported by BMEZ officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-03 | H Erin Xie | — | MIXED | — | −$390.54K |
| 2026-02-03 | Xiang Liu | — | MIXED | — | −$11.83K |
| 2025-12-22 | Robert W Fairbairn | Director | Sell | −20,588 | −$308.42K |
| 2025-04-22 | Saba Capital Management, L.P. | 10%+ Owner | U | −41,501,826 | −$589.74M |
| 2025-02-04 | Xiang Liu | — | MIXED | — | −$3.71K |
| 2025-02-04 | H Erin Xie | — | MIXED | — | −$245.41K |
| 2025-02-04 | Christopher Accettella | — | MIXED | — | −$2.77K |
| 2025-02-04 | Kyle McClements | — | MIXED | — | −$10.05K |
| 2024-10-17 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +129,432 | +$2.05M |
| 2024-10-15 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +30,562 | +$485.02K |
| 2024-10-04 | Christopher Accettella | — | Buy | +1,190 | +$18.05K |
| 2024-10-03 | Boaz Weinstein | 10%+ Owner | Buy | +19,052 | +$300.83K |
| 2024-10-01 | Boaz Weinstein | 10%+ Owner | Buy | +16,024 | +$253.82K |
| 2024-09-30 | Boaz Weinstein | 10%+ Owner | Buy | +99,008 | +$1.57M |
| 2024-09-26 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +600 | +$9.44K |
| 2024-09-24 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +4,012 | +$64.11K |
| 2024-09-23 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +30,910 | +$498.89K |
| 2024-09-19 | Boaz Weinstein | 10%+ Owner | Buy | +95,364 | +$1.52M |
| 2024-04-30 | Kyle McClements | — | Buy | +1,000 | +$14.77K |
| 2024-04-03 | Boaz Weinstein | 10%+ Owner | Buy | +92,842 | +$1.52M |
| 2024-04-01 | Boaz Weinstein | 10%+ Owner | Buy | +32,594 | +$532.26K |
| 2024-03-27 | Boaz Weinstein | 10%+ Owner | Buy | +258,744 | +$4.22M |
| 2024-03-06 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +27,562 | +$448.71K |
| 2024-03-04 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +318,016 | +$5.23M |
| 2024-02-29 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +195,496 | +$3.22M |
| 2024-02-27 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +451,752 | +$7.37M |
| 2024-02-22 | Boaz Weinstein | 10%+ Owner | Buy | +543,240 | +$8.75M |
| 2024-02-21 | Boaz Weinstein | 10%+ Owner | Buy | +535,726 | +$8.52M |
| 2024-02-15 | Boaz Weinstein | 10%+ Owner | Buy | +324,564 | +$5.14M |
| 2024-02-12 | H Erin Xie | — | A | +18,124 deriv. | — |
| 2024-02-12 | Boaz Weinstein | 10%+ Owner | Buy | +575,760 | +$9.19M |
| 2024-02-08 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +340,448 | +$5.37M |
| 2024-02-05 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +294,858 | +$4.59M |
| 2024-02-02 | Christopher Accettella | — | A | +386 deriv. | — |
| 2024-02-02 | Kyle McClements | — | A | +1,401 deriv. | — |
| 2024-02-02 | H Erin Xie | — | MIXED | — | −$114.20K |
| 2024-02-02 | Xiang Liu | — | A | +517 deriv. | — |
| 2024-02-01 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +340,576 | +$5.29M |
| 2024-01-31 | Boaz Weinstein | 10%+ Owner | Buy | +646,890 | +$9.98M |
| 2024-01-26 | Boaz Weinstein | 10%+ Owner | Buy | +1,107,760 | +$16.86M |
| 2024-01-24 | Boaz Weinstein | 10%+ Owner | Buy | +313,360 | +$4.73M |
| 2024-01-23 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +347,950 | +$5.21M |
| 2024-01-18 | Boaz Weinstein | 10%+ Owner | Buy | +279,554 | +$4.17M |
| 2024-01-16 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +331,324 | +$5.04M |
| 2024-01-12 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +144,170 | +$2.19M |
| 2023-12-21 | Boaz Weinstein | 10%+ Owner | Buy | +924,166 | +$13.59M |
| 2023-12-18 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +389,782 | +$5.67M |
| 2023-12-14 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +644,484 | +$9.37M |
| 2023-12-13 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +753,680 | +$10.72M |
| 2023-12-11 | Saba Capital Management, L.P. | 10%+ Owner | Buy | +762,866 | +$10.84M |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| H Erin Xie | — | 25,676 | $434.44K |
| Christopher Accettella | — | 4,509 | $76.29K |
| Kyle McClements | — | 4,273 | $72.30K |
| Robert W Fairbairn | Director | 0 | $14 |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BMEZ quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.